Inactivated Lassa virus elicits a non protective immune response in rhesus monkeys
- 1 May 1992
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 37 (1) , 1-7
- https://doi.org/10.1002/jmv.1890370102
Abstract
We attempted to protect three rhesus monkeys from Lassa fever by vaccination with a preparation of purified whole Lassa virus which had been inactivated by gamma irradiation. The vaccinated monkeys developed antibodies against the three major viral proteins of Lassa virus demonstrated by radioimmunoprecipitation. When the three vaccinated monkeys and two unvaccinated control monkeys were challenged all five became severely ill and died. Prior to death a secondary, high‐titer antibody response to Lassa virus was observed in the three vaccinated monkeys, whereas the two unvaccinated monkeys developed a primary, low‐titer antibody response. Though titers of Lassa virus in serum reached peak levels earlier following challenge in the non vaccinated, at the time of death serum and organ virus liters did not differ significantly. Changes in platelet aggregation, leukocyte counts, and liver enzymes, abnormalities of which have been associated with severity of Lassa fever, were found to be comparable in the two groups. The humoral antibody response measured in these animals following vaccination, although of the same magnitude as found in humans recovered from Lassa fever, was insufficient to protect the animals from this fatal disease. Evidence is now accumulating that the cell‐mediated immune response must be activated in order to protect against challenge with arenaviruses.Keywords
This publication has 22 references indexed in Scilit:
- Lounging in a lysosome: the intracellular lifestyle of Coxiella burnetiiCellular Microbiology, 2007
- Antigenic relatedness between arenaviruses defined at the epitope level by monoclonal antibodiesJournal of General Virology, 1991
- Construction of a recombinant vaccinia virus expressing the Lassa virus glycoprotein gene and protection of guinea pigs from a lethal Lassa virus infectionVirus Research, 1988
- VACCINIA RECOMBINANT EXPRESSING LASSA-VIRUS INTERNAL NUCLEOCAPSID PROTEIN PROTECTS GUINEAPIGS AGAINST LASSA FEVERThe Lancet, 1987
- A Prospective Study of the Epidemiology and Ecology of Lassa FeverThe Journal of Infectious Diseases, 1987
- Lassa FeverNew England Journal of Medicine, 1986
- HLA-RESTRICTED VIRUS-SPECIFIC CYTOTOXIC T-LYMPHOCYTE RESPONSES TO LIVE AND INACTIVATED INFLUENZA VACCINESThe Lancet, 1981
- PROTECTION OF RHESUS MONKEYS FROM LASSA VIRUS BY IMMUNISATION WITH CLOSELY RELATED ARENAVIRUSThe Lancet, 1979
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970